Literature DB >> 3149121

Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study.

T S Salahuddin1, B B Johansson, H Kalimo, Y Olsson.   

Abstract

Infusion of hypertonic solutions into the carotid artery is one method by which the blood-brain barrier (BBB) can be opened transiently in experimental animals. This technique has also been tried in clinical situations in which an enhanced uptake of intravenously injected chemotherapeutic drugs into the brain is desired. We have previously found that infusion of hypertonic mannitol or urea into the carotid artery of the rat, leading to a BBB opening, is associated with light microscopic signs of cellular damage in the brain parenchyma. An electron microscopic study has now been made to obtain more detailed information about the events taking place in the rat brain 1 to 72 h after an intracarotid infusion of hyperosmolar solution of mannitol. Toluidine blue-stained semithin epon sections were also available for high-resolution light microscopy of brain samples from urea-infused animals. Intravenously injected Evan's blue dye was used to confirm that BBB opening had occurred as a consequence of the carotid infusions. The infused hemispheres had numerous structural changes. The dominating light microscopic alteration was the presence of multifocal lesions in the gray or the white matter with closely packed microvacuoles causing status spongiosus. Ultrastructurally the microvacuoles corresponded to very pronounced watery swelling of astrocytic processes and to a minor degree to expansion of dendrites and axons. There was also a light or moderate perivascular astrocytic swelling. In the "spongy" lesions as well as occasionally in non-vacuolated parts of the cerebral cortex, there were collapsed electron-dense neurons with pronounced mitochondrial alterations such as severe swelling associated with rupture of christae.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149121     DOI: 10.1007/bf00688236

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

Authors:  E A Neuwelt; J Howieson; E P Frenkel; H D Specht; R Weigel; C G Buchan; S A Hill
Journal:  Neurosurgery       Date:  1986-10       Impact factor: 4.654

Review 2.  The blood-brain barrier. Transport across the cerebral endothelium.

Authors:  M W Bradbury
Journal:  Circ Res       Date:  1985-08       Impact factor: 17.367

Review 3.  Structural aspects of brain barriers, with special reference to the permeability of the cerebral endothelium and choroidal epithelium.

Authors:  B van Deurs
Journal:  Int Rev Cytol       Date:  1980

4.  Cerebral blood flow and glucose utilization following opening of the blood-brain barrier and during maturation of the rat brain.

Authors:  S I Rapoport; M Ohata; E D London
Journal:  Fed Proc       Date:  1981-06

5.  Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.

Authors:  E A Neuwelt; H D Specht; P A Barnett; S A Dahlborg; A Miley; S M Larson; P Brown; K F Eckerman; K E Hellström; I Hellström
Journal:  Neurosurgery       Date:  1987-06       Impact factor: 4.654

6.  Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning.

Authors:  E A Neuwelt; H D Specht; J Howieson; J E Haines; M J Bennett; S A Hill; E P Frenkel
Journal:  AJR Am J Roentgenol       Date:  1983-10       Impact factor: 3.959

7.  Osmotic opening of the blood-brain barrier and local cerebral glucose utilization.

Authors:  H M Pappius; H E Savaki; C Fieschi; S I Rapoport; L Sokoloff
Journal:  Ann Neurol       Date:  1979-03       Impact factor: 10.422

8.  Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.

Authors:  M K Spigelman; R A Zappulla; J A Strauchen; E J Feuer; J Johnson; S J Goldsmith; L I Malis; J F Holland
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

Review 9.  Observations on exsudation of fibronectin, fibrinogen and albumin in the brain after carotid infusion of hyperosmolar solutions. An immunohistochemical study in the rat indicating longlasting changes in the brain microenvironment and multifocal nerve cell injuries.

Authors:  T S Salahuddin; H Kalimo; B B Johansson; Y Olsson
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  The temporal evolution of hypoglycemic brain damage. I. Light- and electron-microscopic findings in the rat cerebral cortex.

Authors:  R N Auer; H Kalimo; Y Olsson; B K Siesjö
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

View more
  19 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

Review 3.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 4.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 5.  Getting into the brain: approaches to enhance brain drug delivery.

Authors:  Mayur M Patel; Bhoomika R Goyal; Shraddha V Bhadada; Jay S Bhatt; Avani F Amin
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Alzheimer's disease drug development and the problem of the blood-brain barrier.

Authors:  William M Pardridge
Journal:  Alzheimers Dement       Date:  2009-09       Impact factor: 21.566

7.  Neuropathology of degenerative cell death in Caenorhabditis elegans.

Authors:  D H Hall; G Gu; J García-Añoveros; L Gong; M Chalfie; M Driscoll
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

Review 8.  Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.

Authors:  Mayur M Patel; Bhoomika M Patel
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

Review 9.  Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound.

Authors:  Charissa Poon; Dallan McMahon; Kullervo Hynynen
Journal:  Neuropharmacology       Date:  2016-02-18       Impact factor: 5.250

10.  Glutamate enhances brain damage and albumin content in cerebrospinal fluid after intracarotid protamine infusion.

Authors:  I Westergren; C Nordborg; B B Johansson
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.